Mechanisms of error-free cell division after whole-genome doubling
Mechanisms of error-free cell division after whole-genome doubling
批准号:
9750286
负责人:
Prasad V Jallepalli
金额:
$7.62万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2019-11-30
关键词:
AneuploidyBindingBiosensorBuffersCCNE1 geneCancer cell lineCell SurvivalCell divisionCellsCentrosomeChromosomal InstabilityChromosome SegregationChromosomesComplexDataDiploid CellsDiploidyEnsureEssential GenesEventEvolutionFluorescence Resonance Energy TransferFrequenciesGeneticGenome StabilityGoalsHumanHuman Cell LineImmunofluorescence ImmunologicIn VitroIndividualKinetochoresKnowledgeMalignant NeoplasmsMicrotubulesMissense MutationMitosisMitoticMitotic spindleMolecularMutationOutcomePathway interactionsPhosphorylationPhosphorylation SitePloidiesPolyploid CellsProtein phosphataseRecurrenceRegulationResearchResolutionRouteSignal TransductionStressSubstrate SpecificityTP53 geneTestingTetraploidyTherapeuticTimeWorkbasecancer cellcellular imagingchromosome losschromosome missegregationcostexperiencefitnesshigh resolution imagingimprovedin vivoinnovationlive cell imagingmutantneoplastic cellphosphoproteomicsprotein phosphatase 2A regulatory subunit 65 kDascaffoldtherapeutic targettumortumorigenesiswhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
A prevalent route to aneuploidy for diploid cells is the occurrence of a Whole-Genome Doubling (WGD)
followed by chromosome loss. WGD buffers against deleterious effects of changes in essential genes during
tumor cell evolution. However, WGD also results in a doubling of centrosome content, which can be
deleterious during mitosis. This is because each of the centrosomes nucleates microtubules, resulting in a
multipolar spindle. There are two potential outcomes when this happens: cells can initiate a multipolar division,
which is lethal, or they can re-organize the multipolar spindle into a bipolar spindle by clustering the extra
centrosomes. The latter outcome allows for bipolar cell division and survival, but with an increased rate of
chromosome segregation errors. After WGD, normal untransformed human cells experience both cell division
outcomes with approximately equal frequency. Cancer cell lines, by contrast, are generally more proficient at
clustering extra centrosomes, but how this occurs is not known. The long-term goal of this work, therefore, is to
define mechanisms that allow cells to survive mitosis after WGD. The overall objective of this proposal is to
define how cancer-associated mutations and deletions in protein phosphatase 2A (PP2A) alter mitosis after
WGD. The central hypothesis is that PP2A inactivation increases the viability of cells after WGD through
enhanced centrosome clustering and reduction in chromosome segregation errors. This hypothesis is based
on studies of a prevalent mis-sense mutation in PP2A-A, a core component of heterotrimeric PP2A complexes.
The rationale for the proposed research is that knowledge of how cancer cells mitigate the stress associated
with WGD, and more specifically, how recurrent PP2A-A mutations change mitosis, could potentially be used
to therapeutically target those pathways in cancer cells. Our objective will be realized by the following two
aims: (1) Identify how PP2A controls centrosome clustering. Phosphorylation of NuMA and TPX2, two
regulators of spindle assembly, is altered by PP2A-A mutation. Complementary in vivo and in vitro approaches
will be used to determine how this impacts centrosome clustering after WGD. (2) Identify how PP2A controls
the fidelity of chromosome segregation. High-resolution live-cell imaging, FRET-based phosphorylation
biosensors, and quantitative immunofluorescence of endogenous kinetochore substrates will be used to test
the hypothesis that PP2A-A mutation reduces chromosome segregation errors through altered phospho-
signaling at kinetochores. The long-term impact of PP2A-A mutation on genome stability in cells that
experience WGD will also be determined. Successful completion of this work will establish how human cancers
`fine-tune' phosphorylation to ensure proliferation after WGD. This knowledge could inform on strategies to
target tumor cells with ploidy changes or supernumerary centrosomes.
!
!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Chromosome Segregation in Human Cells
-
批准号:7426439
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:8469523
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:8697767
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:8075456
-
项目类别:
-
资助金额:$38.74万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:10180979
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:6918125
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:7886056
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:7623610
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:8286240
-
项目类别:
-
资助金额:$38.74万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:7247247
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:9274830
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
Regulation of Chromosome Segregation in Human Cells
-
批准号:7067074
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2005
-
负责人:Prasad V Jallepalli
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: